Clinical Trial Update: Omalizumab for Plant-Food Allergy Due to Sensitization to LTP or Profilin

View source ↗

Summary

Omalizumab is being studied for plant-food allergy caused by sensitization to lipid transfer protein (LTP) or profilin; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Food Allergies | Status: NOT_YET_RECRUITING